Reporting owner
Davis Matthew W.
Reporting owner CIK 0002094283 · Chief Development Officer
These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
2 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Nov 10, 2025 | Aquestive Therapeutics, Inc.Non-Qualified Stock Option (right to buy) | Davis Matthew W. | Stock award |
| Nov 10, 2025 | Aquestive Therapeutics, Inc.Common Stock | Davis Matthew W. | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transactions in associated filings
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | Aquestive Therapeutics, Inc.AQST · company listings | Davis Matthew W.Chief Development Officer | Stock awardNon-Qualified Stock Option (right to buy)Derivative security · Code A | 50,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Aquestive Therapeutics, Inc.AQST · company listings | Davis Matthew W.Chief Development Officer | Stock awardCommon StockNon-derivative security · Code A | 50,000 | 0Value: 0Currency not specified | View ↗ |
2 transactions on this page. Filing date, newest first.